Search for: "In Re: Darvocet, Darvon and Propoxyphene Products Liability Litigation MDL 2226" Results 1 - 9 of 9
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Sixth Circuit to Review Generic Drug Preemption Case
10 Apr 2012, 2:33 pm by Carlee Hobbs Toth
Plaintiffs in the federal multi-district litigation In re: Darvocet, Darvon and Propoxyphene Products Liability Litigation, Case No. 11-md-2226-DCR, MDL Docket No. 2226, raised a host of claims against generic manufacturers of the drug propoxyphene (a generic equivalent of Darvon) that the Eastern District of Kentucky recently dismissed as either preempted by Mensing or inadequately… [read post]
Sixth Circuit Appellate Blog - http://www.sixthcircuitappellateblog.com/
The Sixth Circuit Applies Bartlett and Mensing to Preempt Claims Against Generic Drugmakers
30 Jun 2014, 6:07 am by Colter Paulson
It’s been more than two years since we reported on the appeal in the Darvocet MDL (In re: Darvocet, Darvon and Propoxyphene Products Liability Litigation, No. 11-md-2226-DCR, MDL 2226), which involves claims against generic manufacturers of a generic equivalent of the drug Darvon. [read post]
Sixth Circuit Appellate Blog - http://www.sixthcircuitappellateblog.com/
Breaking News - Bartlett Goes Nowhere In Darvocet
22 Jun 2012, 2:23 pm by Bexis
  See In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, MDL No. 2226, slip op. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Sixth Circuit to Review Generic Drug Preemption Case
10 Apr 2012, 2:33 pm by Carlee Hobbs Toth
  Plaintiffs in the federal multi-district litigation In re: Darvocet, Darvon and Propoxyphene Products Liability Litigation, Case No. 11-md-2226-DCR, MDL Docket No. 2226, raised a host of claims against generic manufacturers of the drug propoxyphene (a generic equivalent of Darvon) that the Eastern District of Kentucky recently dismissed as either preempted by Mensing or… [read post]
Sixth Circuit Appellate Blog - http://www.sixthcircuitappellateblog.com/
Drug and Device MDL Update
14 Feb 2012, 11:50 am by Michelle Yeary
Combination Aspirin Products Marketing and Sales Practices Litigation (no website)MDL - 2051 IN RE: Denture Cream Products Liability Litigation MDL - 2066 IN RE: Oral Sodium Phosphate Solution-Based Products Liability Litigation MDL - 2067 IN RE: Celexa and Lexapro Marketing and Sales Practices Litigation (no website)MDL - 2087 IN RE:… [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Almost a Mass Action . . . But This Isn’t Horseshoes
6 Aug 2013, 12:18 pm by Michelle Yeary
  In re Darvocet, Darvon and Propoxyphene Products Liability Litigation, MDL 2226, 2013 U.S. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
The New One-Two - Heavyweight Division
8 Mar 2012, 10:08 am by Bexis
In In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, MDL No. 2226, slip op. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Another Homework Failure By Plaintiffs
15 May 2012, 11:26 am by Michelle Yeary
  In re: Darvocet, Darvon and Propoxyphene Products Liability Litigation, MDL Docket No. 2226 (E.D. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
“RLD Theory of Liability” Continues to Fall Flat; Multiple Court Decisions Build Momentum in Generic Drug Failure-to-Warn Preemption Litigation
19 Mar 2012, 1:31 am by FDABlog HPM
” Finally, in In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, MDL Docket No. 2226 (E.D. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/